Does the Framingham cardiovascular disease risk score also have predictive utility for dementia death? An individual participant meta-analysis of 11,887 men and women

Atherosclerosis

Volumn 228, Issue 1, 2013, Pages 256-258

  Russ, Tom C ^a,b   Hamer, Mark ^c   Stamatakis, Emmanuel ^c   Starr, John M ^a,b   Batty, G David ^a,c   Kivimäki, Mika ^c  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b HEALTHCARE IMPROVEMENT SCOTLAND   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Cardiovascular disease; Dementia; Framingham study; Meta analysis; Mortality; Prediction; Risk

Indexed keywords

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; COHORT ANALYSIS; CONTROLLED STUDY; DEMENTIA; DISEASE ASSOCIATION; FEMALE; FRAMINGHAM RISK SCORE; FRONTOTEMPORAL DEMENTIA; HAZARD RATIO; HEART FAILURE; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; META ANALYSIS (TOPIC); MORTALITY; MULTICENTER STUDY; PERIPHERAL VASCULAR DISEASE; POPULATION BASED CASE CONTROL STUDY; PREDICTIVE VALUE; PRIORITY JOURNAL; RISK FACTOR;

ADULT; AGED; CARDIOVASCULAR DISEASES; COHORT STUDIES; DEMENTIA; FEMALE; HUMANS; MALE; MASSACHUSETTS; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; RISK FACTORS;

EID: 84876805520     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2013.02.020     Document Type: Article

References (15)

1. Stephan B.C.M., Brayne C. Vascular factors and prevention of dementia. Int Rev Psychiatry 2008, 20:344-356.
2. Pendlebury S.T., Rothwell P.M. Prevalence, incidence, and factors associated with pre-stroke and post-stroke dementia: a systematic review and meta-analysis. Lancet Neurol 2009, 8:1006-1018.
3. D'Agostino R.B., Vasan R.S., Pencina M.J., et al. General cardiovascular risk profile for use in primary care. Circulation 2008, 117:743-753.
4. Kaffashian S., Dugravot A., Nabi H., et al. Predictive utility of the Framingham general cardiovascular disease risk profile for cognitive function: evidence from the Whitehall II Study. Eur Heart J 2011, 32:2326-2332.
5. Wolf P.A. Contributions of the Framingham Heart Study to stroke and dementia epidemiologic research at 60 years. Arch Neurol 2012, 69:567-571.
6. Mindell J., Biddulph J.P., Hirani V., et al. Cohort profile: the health survey for England. Int J Epidemiol 2012, 41:1585-1593.
7. Russ T.C., Stamatakis E., Hamer M., Starr J.M., Kivimaki M., Batty G.D. Association between psychological distress and mortality: individual participant pooled analysis of 10 prospective cohort studies. Brit Med J 2012, 345:e4933.
8. Kim H.C., Greenland P., Rossouw J.E., et al. Multimarker prediction of coronary heart disease risk: the Women's Health Initiative. J Am Coll Cardiol 2010, 55:2080-2091.
9. Russ T.C., Batty G.D., Starr J.M. Cognitive and behavioural predictors of survival in Alzheimer disease: results from a sample of treated patients in a tertiary-referral memory clinic. Int J Geriatr Psychiatry 2012, 27:844-853.
10. Harris M., Blundell J. Audit of necropsies in a British district general hospital. J Clin Pathol 1991, 44:862-865.
11. Lo R.Y., Hubbard A.E., Shaw L.M., et al. Longitudinal change of biomarkers in cognitive decline. Arch Neurol 2011, 68:1257-1266.
12. Landau S., Harvey D., Madison C., et al. Comparing predictors of conversion and decline in mild cognitive impairment. Neurology 2010, 75:230-238.
13. Jonsson T., Atwal J.K., Steinberg S., et al. A mutation in APP protects against Alzheimer's disease and age-related cognitive decline. Nature 2012, 488:96-99.
14. Harold D., Abraham R., Hollingworth P., et al. Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease. Nat Genet 2009, 41:1088-1093.
15. Naj A.C., Jun G., Beecham G.W., et al. Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease. Nat Genet 2011, 43:436-441.